Joshua D. King, BS, MBA

Josh King is the Vice President of Marketing at HistoSonics, a pioneering medical technology company developing and commercializing histotripsy—the world’s first non-invasive platform that destroys, liquefies and eliminates tumors and diseased tissues without incisions. In his role, Josh leads global marketing strategy, brand development, and market expansion initiatives to accelerate adoption of the company’s breakthrough Edison™ Histotripsy System.

With extensive experience in healthcare marketing and commercialization, Josh has built his career at the intersection of cutting-edge medical technology and patient impact. He specializes in translating complex clinical innovations into compelling value propositions that resonate with physicians, health systems, payors, and patients.

Prior to joining HistoSonics, Josh held senior marketing roles in the medical device sector, where he successfully led product launches and international market entry strategies. His expertise spans strategic marketing and global market access, with a strong background in biology and medical physics.